Yiren Hu

2.0k total citations · 1 hit paper
45 papers, 1.4k citations indexed

About

Yiren Hu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yiren Hu has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yiren Hu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer-related molecular mechanisms research (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yiren Hu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer-related molecular mechanisms research (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Yiren Hu collaborates with scholars based in China, United States and Hong Kong. Yiren Hu's co-authors include Mingzhe Ma, Mingzhe Weng, Kun Lv, Hui Yang, Michael G. Rosenfeld, Xiaocen Liu, Ye Hu, Ping Wan, Qi Ma and Yan Zhang and has published in prestigious journals such as Cell, Molecular Cell and Free Radical Biology and Medicine.

In The Last Decade

Yiren Hu

39 papers receiving 1.4k citations

Hit Papers

Hypoxia inducible lncRNA-CBSLR modulates ferroptosis thro... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiren Hu China 19 1.0k 549 241 189 115 45 1.4k
So Mee Kwon South Korea 18 510 0.5× 337 0.6× 140 0.6× 199 1.1× 143 1.2× 29 892
Zhanjun Guo China 21 903 0.9× 433 0.8× 123 0.5× 180 1.0× 84 0.7× 94 1.3k
Tae Matsumura Japan 15 1.1k 1.1× 900 1.6× 120 0.5× 290 1.5× 168 1.5× 66 1.6k
Kejun Nan China 24 1.1k 1.0× 829 1.5× 230 1.0× 435 2.3× 124 1.1× 60 1.6k
Zhen‐Bo Feng China 23 1.2k 1.2× 990 1.8× 249 1.0× 291 1.5× 96 0.8× 100 1.7k
Jin He China 16 570 0.6× 356 0.6× 98 0.4× 167 0.9× 90 0.8× 47 907
Pinzhu Huang China 18 513 0.5× 289 0.5× 122 0.5× 270 1.4× 137 1.2× 50 978
Yangfan Lv China 16 583 0.6× 359 0.7× 130 0.5× 205 1.1× 87 0.8× 31 892
Dongdong Lu China 22 1.2k 1.2× 1.0k 1.9× 84 0.3× 177 0.9× 97 0.8× 46 1.6k
Cheol-Keun Park South Korea 23 682 0.7× 441 0.8× 200 0.8× 371 2.0× 250 2.2× 48 1.3k

Countries citing papers authored by Yiren Hu

Since Specialization
Citations

This map shows the geographic impact of Yiren Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiren Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiren Hu more than expected).

Fields of papers citing papers by Yiren Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiren Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiren Hu. The network helps show where Yiren Hu may publish in the future.

Co-authorship network of co-authors of Yiren Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiren Hu. A scholar is included among the top collaborators of Yiren Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiren Hu. Yiren Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Bo, Hongxing Zheng, Li‐Dong Huang, et al.. (2025). Correlation between gallstones and fasting blood glucose to serum high-density lipoprotein cholesterol ratio among American adults. Frontiers in Medicine. 12. 1528613–1528613. 1 indexed citations
3.
Zheng, Hongxing, Bo Wu, Li Min, et al.. (2025). Cardiometabolic index as a predictor of gallstone risk: evidence from NHANES 2017–2020. BMC Gastroenterology. 25(1). 218–218.
5.
He, Xiaoli, Yiren Hu, Wei Liu, et al.. (2022). Deciphering the Effective Constituents and Mechanisms of Portulaca oleracea L. for Treating NASH via Integrating Bioinformatics Analysis and Experimental Pharmacology. Frontiers in Pharmacology. 12. 818227–818227. 9 indexed citations
6.
Bao, Dandan, Yiren Hu, Chenghao Zhang, et al.. (2022). Perioperative and short-term outcomes of laparoscopic liver resection for recurrent hepatocellular carcinoma: A retrospective study comparing open hepatectomy. Frontiers in Oncology. 12. 956382–956382. 3 indexed citations
7.
Bao, Dandan, Chenghao Zhang, Longlong Li, et al.. (2021). Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. Frontiers in Oncology. 10. 553297–553297. 26 indexed citations
9.
Yang, Hui, Yiren Hu, Mingzhe Weng, et al.. (2021). Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. Journal of Advanced Research. 37. 91–106. 190 indexed citations breakdown →
10.
Nair, Sreejith J., Yang Lu, Dario Meluzzi, et al.. (2019). Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly. Nature Structural & Molecular Biology. 26(3). 193–203. 238 indexed citations
11.
Zhang, Fan, Chong‐De Lu, Xiuping Zhang, et al.. (2019). The impact of portal vein tumor thrombus on long-term survival after liver resection for primary hepatic malignancy. HPB. 22(7). 1025–1033. 9 indexed citations
12.
Hu, Yiren, et al.. (2019). miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R. Pathology - Research and Practice. 215(12). 152674–152674. 34 indexed citations
13.
Zhang, Xiuping, Tengfei Zhou, Zhiheng Wang, et al.. (2019). Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study. Annals of Surgical Oncology. 26(12). 4117–4125. 20 indexed citations
14.
Gao, Weiwei, Rong-quan Xiao, Wenjuan Zhang, et al.. (2018). JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. Molecular Cell. 70(2). 340–357.e8. 68 indexed citations
15.
Ma, Mingzhe, et al.. (2018). Prognostic Value of Inflammatory Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model. Digestive Surgery. 36(5). 433–442. 14 indexed citations
16.
Tan, Yuliang, Chunyu Jin, Wubin Ma, et al.. (2018). Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program. Molecular Cell. 71(4). 526–539.e8. 16 indexed citations
17.
Hu, Yiren, et al.. (2017). The Progression of Atrophic Gastritis to Gastric Cancer: A Retrospective Study in 61,810 Cases. Journal of Cancer Therapy. 8(6). 553–560. 1 indexed citations
18.
Zhang, Yi, et al.. (2017). Long noncoding RNA linc00462 promotes hepatocellular carcinoma progression. Biomedicine & Pharmacotherapy. 93. 40–47. 27 indexed citations
19.
Li, Wenbo, Yiren Hu, Soohwan Oh, et al.. (2015). Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. Molecular Cell. 59(2). 188–202. 85 indexed citations
20.
Wen, Hong, et al.. (2014). Percutaneous quadriceps tendon pie-crusting release of extension contracture of the knee. Orthopaedics & Traumatology Surgery & Research. 100(3). 333–335. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026